Válter R Fonseca

MD, PhD
Director, Department for Healthcare Quality @DGSaude
Chair, COVID-19 NITAG @DGSaude
Professor @medicina_lisboa

[Luis Graca @lgraca]

Proud to present BA.5-infection risk drops after BA.1/BA.2 infection – data from the national Portuguese registry, one of the countries first hit with BA.5. Important, as adapted vaccines in development are BA.1-based. Follow the twitorial! 1/9 @lgraca https://t.co/b7ni4POUhw

[Válter R Fonseca @VlterRFonseca1]

WORTH THINKING: "National public health agencies have a wealth of relevant expertise and contribute an important population health perspective in assessing evidence from a range of other (epidemiological, statistical and clinical) disciplines."
https://t.co/cYdvcjSjlo

[Válter R Fonseca @VlterRFonseca1]

"Trust remains critical to ending pandemics. Achieving it requires transparency, openness and willingness to embrace uncertainty."

[The New York Times @nytimes]

In Opinion

In Denmark, "high trust and a sense of community have made Covid policy easier," write three Danish researchers in a guest essay. "When vaccines were approved, Danes quickly got vaccinated." https://t.co/lqUmdOo1ti

[Válter R Fonseca @VlterRFonseca1]

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza | NEJM https://t.co/srLmafA4qD

[Válter R Fonseca @VlterRFonseca1]

WHO/Europe “Meeting of Minds” on ensuring quality of care post-COVID-19 https://t.co/4vnQ2jRiHT
This great initiative from WHO Europe will bring together new insights for the future of healthcare. Almost there! See you in Athens.
#healthcarequality

[Válter R Fonseca @VlterRFonseca1]

SPP TV | Dia 13 | Comissão de Trabalho de Infeciologia Respiratória https://t.co/uNCbClEeRt via @YouTube